Becton Dickinson Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

Becton Dickinson verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 12%, während die Gewinne der Branche Medical Equipment jährlich um gewachsen und zwar um 13.2%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 3.1%. Die Eigenkapitalrendite von Becton Dickinson beträgt 5.6% und die Nettomargen betragen 7.4%.

Wichtige Informationen

12.0%

Wachstumsrate der Gewinne

11.0%

EPS-Wachstumsrate

Medical Equipment Wachstum der Industrie8.9%
Wachstumsrate der Einnahmen3.1%
Eigenkapitalrendite5.6%
Netto-Marge7.4%
Nächste Ertragsaktualisierung06 Feb 2025

Jüngste Aktualisierungen vergangener Leistungen

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Recent updates

Becton, Dickinson and Company Q4: Shifting To High-Growth Areas

Nov 12

Are Becton, Dickinson and Company (NYSE:BDX) Investors Paying Above The Intrinsic Value?

Oct 22
Are Becton, Dickinson and Company (NYSE:BDX) Investors Paying Above The Intrinsic Value?

Here's Why Becton Dickinson (NYSE:BDX) Can Manage Its Debt Responsibly

Sep 30
Here's Why Becton Dickinson (NYSE:BDX) Can Manage Its Debt Responsibly

Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery

Sep 13

Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Aug 06

Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

Jul 16
Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Jun 27
An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

May 24
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

Becton, Dickinson and Company: Stagnating All Along

May 16

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23
Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29
Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08
Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03
Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30
Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12
Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05
With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13
We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28
Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22
Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Aufschlüsselung der Einnahmen und Ausgaben

Wie Becton Dickinson Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

NYSE:BDX Einnahmen, Ausgaben und Erträge (USD Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 2419,8281,4594,8471,169
31 Mar 2419,7161,3644,8291,175
31 Dec 2319,4921,2654,8431,214
30 Sep 2319,3721,4704,8171,237
30 Jun 2319,0461,5824,8481,256
31 Mar 2318,8091,5564,7911,266
31 Dec 2218,7381,4864,7511,255
30 Sep 2218,8701,5454,7261,256
30 Jun 2218,9581,4124,7741,324
31 Mar 2218,9241,4304,8451,339
31 Dec 2118,5341,0794,7501,302
30 Sep 2119,1311,5144,7201,279
30 Jun 2119,0661,4864,6321,210
31 Mar 2118,3131,3794,4091,142
31 Dec 2018,2071,5074,3461,117
30 Sep 2016,0742454,1781,039
30 Jun 2016,9177864,2161,067
31 Mar 2017,4149234,3131,057
31 Dec 1917,3557604,3791,044
30 Sep 1917,2901,0814,3341,032
30 Jun 1917,1087844,3451,039
31 Mar 1917,0369264,3531,063
31 Dec 1817,0638944,3251,071
30 Sep 1815,9831594,0291,004
30 Jun 1814,7476213,689947
31 Mar 1813,503-993,325857
31 Dec 1712,2512942,991783
30 Sep 1712,0931,0302,953770
30 Jun 1712,1587592,947807
31 Mar 1712,3211,3142,957827
31 Dec 1612,4191,3092,966823
30 Sep 1612,4839763,005828
30 Jun 1612,3121,1392,966771
31 Mar 1612,2348102,988743
31 Dec 1511,2176882,767690
30 Sep 1510,2826952,563632
30 Jun 159,4108152,350570
31 Mar 158,4481,0792,127529
31 Dec 148,4681,1502,141527
30 Sep 148,4461,1852,145524
30 Jun 148,3459742,117522
31 Mar 148,2399412,102506
31 Dec 138,1699302,091502

Qualität der Erträge: BDX hat einen großen einmalig Verlust von $752.0M, der sich auf die Finanzergebnisse der letzten 12 Monate auswirkt, an 30th June, 2024.

Wachsende Gewinnspanne: BDXDie aktuellen Gewinnspannen (7.4%) sind niedriger als im letzten Jahr (8.3%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: BDXIn den letzten 5 Jahren sind die Gewinne von 12% jährlich gestiegen.

Beschleunigtes Wachstum: BDXDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: BDX hatte im vergangenen Jahr ein negatives Gewinnwachstum (-7.8%), was einen Vergleich mit dem Branchendurchschnitt Medical Equipment (11.7%) erschwert.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: BDXDie Eigenkapitalrendite des Unternehmens (5.6%) wird als niedrig angesehen.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren